4th Tumor Myeloid Targeting Therapies Summit 2024
Evvnt Promotion / evvnt
11.06.2024 - 13.06.2024 Hilton Boston Back Bay, 40 Dalton Street, 02115 Boston, Massachusetts, USA
Time: 8:00 AM - 5:00 PM
Temi della conferenza
The landscape of innate immune cells is rapidly advancing towards clinical applications. Multiple published studies in the last year repeatedly affirm that targeting myeloid cells rather than the cancer cells themselves can shrink tumors, further providing confidence in their potential as a clinically effective therapeutic.
The landscape of innate immune cells is rapidly advancing towards clinical applications. Multiple published studies in the last year repeatedly affirm that targeting myeloid cells rather than the cancer cells themselves can shrink tumors, further providing confidence in their potential as a clinically effective therapeutic.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/2219781-3?pid=4832
Speakers: Akshata Udyavar, Senior Director, Actym Therapeutics, Peter Ellmark, CSO, Alligator Bioscience, Stephanie Casey Parks, Principal Scientist, Amgen, and more
Brochure: https://go.evvnt.com/2219781-3?pid=4832
Speakers: Akshata Udyavar, Senior Director, Actym Therapeutics, Peter Ellmark, CSO, Alligator Bioscience, Stephanie Casey Parks, Principal Scientist, Amgen, and more
Informazioni ed Iscrizioni:
https://go.evvnt.com/2219781-2?pid=4832
Mr. Luke Kelly
Oncologia
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
